Page last updated: 2024-08-23

6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid and Age-Related Macular Degeneration

6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid has been researched along with Age-Related Macular Degeneration in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arnold, C; Böhm, V; Dawczynski, J; Fröhlich, K; Jahreis, G; Jentsch, S; Winter, L1

Trials

1 trial(s) available for 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid and Age-Related Macular Degeneration

ArticleYear
Macular xanthophylls and ω-3 long-chain polyunsaturated fatty acids in age-related macular degeneration: a randomized trial.
    JAMA ophthalmology, 2013, Volume: 131, Issue:5

    Topics: Aged; Aged, 80 and over; Antioxidants; Capsules; Chromans; Chromatography, High Pressure Liquid; Docosahexaenoic Acids; Double-Blind Method; Eicosapentaenoic Acid; Fatty Acids, Omega-3; Female; Gas Chromatography-Mass Spectrometry; Humans; Lipids; Lutein; Macular Degeneration; Male; Middle Aged; Retinal Pigments; Visual Acuity; Xanthophylls; Zeaxanthins

2013